Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases
Gain-of-function mutations in the Type I Bone Morphogenic Protein (BMP) receptor ACVR1 have been identified in two diseases: Fibrodysplasia Ossificans Progressiva (FOP), a rare autosomal dominant disorder characterized by genetically driven heterotopic ossification, and in 20 –25% of Diffuse Intrinsic Pontine Gliomas (DIPGs), a pediatric brain tumor with no effective therapies and dismal median survival. While the ACVR1 mutation is causal for FOP, its role in DIPG tumor biology remains under active investigation.
Source: Bone - Category: Orthopaedics Authors: Harry J. Han, Payal Jain, Adam C. Resnick Tags: Full Length Article Source Type: research
More News: Biology | Brain | Brain Cancers | Brain Tumor | Fibrodysplasia Ossificans Progressiva | Genetics | Glioma | Neurology | Orthopaedics | Pediatrics | Rare Diseases